Cayce Denton

Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.

Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts.

PatientSafe Solutions, Inc. provides wireless workflow optimization and patient safety solutions. It designs hardware and software solutions to provide patient safety and improve patient, family, and nurse satisfaction in hospitals. It offers clinical communications and workflows, coordinated care, and professional services. The company was founded by Keith Blei, Gerald E. Forth, David D. Swenson, Pat Steusloff and Kim T. Rubin in 2002 and is headquartered in San Diego, CA.

Karos Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. The firm focuses on bone related, pulmonary arterial hypertension and other orphan diseases. The company was founded in 2009 and is headquartered in New Haven, CT.

Spark Diagnostics, Inc. provides diagnostic services. It uses sequencing technology to diagnose diseases. The company was founded by Jessica Owens in 2011 and is headquartered in San Francisco, CA.

Tarrant Capital IP LLC operates as a venture capital firm. It serves the consumer, retail, technology, internet, healthcare, energy, cleantech, digital media, real estate, renewables and transportation industries. The company was founded by David Bonderman and Jim Coulter in 1992 and is headquartered in San Francisco, CA.

Locana, Inc. engages in the provision of ribonucleic acid targeting gene therapy. Its platform technology addresses a wide spectrum of human genetic diseases. It has advanced a powerful modular RNA targeting-effector approach to optimize and advance therapeutic candidates that is distinct from DNA-targeted approaches and nucleic acid-based RNA targeting. The company was founded by Gene Yeo and David Nelles in 2016 and is headquartered in San Diego, CA.